![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1635849
½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ½ÃÀå : Á¦°øº°, ±â¼úº°, ÀûÀÀÁõº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Artificial Intelligence in Neurology Operating Room Market by Offering, Technology, Indication, Application, End User, and Region 2025-2033 |
½Å°æ¿Ü°ú ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI) ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 6,360¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â¿¡´Â 12¾ï 9,700¸¸ ´Þ·¯¿¡ ´ÞÇØ 2025³âºÎÅÍ 2033³â±îÁö 39.8%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î »ê¾÷, ½ÉÀå ¹× »óó ÇÕº´Áõ ¿¹ÃøÀ» À§ÇÑ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼ÀÇ AI Ȱ¿ë Áõ°¡, AI ±â¹Ý ·Îº¿ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.
ÀΰøÁö´É(AI)Àº ÄÄÇ»ÅÍ ÇÁ·Î±×·¥À̳ª ±â°è¸¦ ÅëÇØ Àΰ£ÀÇ Áö´É °úÁ¤À» ½Ã¹Ä·¹À̼ÇÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. Àü¹®°¡ ½Ã½ºÅÛ, ÀÚ¿¬¾î ó¸®, À½¼º ÀνÄ, ¸Ó½ÅºñÀüÀ¸·Î ±¸¼ºµÇ¸ç, AI´Â ±â°è ÇнÀ(ML) ¾Ë°í¸®ÁòÀÇ »ý¼º ¹× ÇнÀÀ» À§ÇÑ °ÈµÈ Çϵå¿þ¾î ¹× ¼ÒÇÁÆ®¿þ¾î ±â¹Ý¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. ½Ç¼ö¸¦ ÁÙÀ̰í, À§ÇèÇÑ ÀÛ¾÷À» ¼öÇàÇϸç, ´Ù¾çÇÑ ÀÛ¾÷À» ½¬Áö ¾Ê°í ÀÚµ¿ÈÇϱâ À§ÇØ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ´ë·®ÀÇ ¶óº§ÀÌ ºÙÀº ÇнÀ µ¥ÀÌÅ͸¦ ¼öÁýÇϰí, µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© »ó°ü°ü°è¿Í ÆÐÅÏÀ» ã°í, ÀÌ·¯ÇÑ ÆÐÅÏÀ» »ç¿ëÇÏ¿© ¹Ì·¡ »óÅ¿¡ ´ëÇÑ ¿¹ÃøÀ» ¼öÇàÇÕ´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í µ¥ÀÌÅ͸¦ ½Ç¿ëÀûÀÎ Á¤º¸·Î º¯È¯ÇÏ¿© ƯÁ¤ ÀÛ¾÷À» »ý¼ºÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ÇöÀç ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼´Â ¿Ü°ú ÀÇ»çÀÇ ¼º°ú¸¦ ³ôÀÌ°í ½Å°æ¿Ü°ú ¼ö¼ú°ú °ü·ÃµÈ ¿À·ù¸¦ ÁÙÀ̱â À§ÇØ AI¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¿¹ÈÄ ¿¹Ãø, ÀáÀçÀûÀÎ ¼ö¼ú ÈÄ ÇÕº´Áõ ½Äº°, ´õ ³ªÀº »çÈÄ °ü¸® ¹× ȸº¹À» À§ÇÑ µ¥ÀÌÅÍ ÃßÀûÀ» À§ÇÑ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼ÀÇ AI ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, Àü ¼¼°èÀûÀ¸·Î °æÃß Àü¹æ Ãß°£ÆÇ ÀýÁ¦¼ú(ACDF)À» ¹Þ´Â ȯÀÚÀÇ À§Çè ¿äÀÎÀ» ½Äº°Çϰí, ½ÉÀå ÇÕº´Áõ, »óó ÇÕº´Áõ, »ç¸Á·üÀ» ¿¹ÃøÇϱâ À§ÇØ ½Å°æ¿Ü°ú ¼ö¼ú½Ç¿¡¼ AIÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÇコÄÉ¾î »ê¾÷ÀÇ ¹ø¿µ°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ¼öÁý, ºÐ¼®, ó¸® ¹× º¸±ÞÀ» À§ÇØ ½Å°æ¿Ü°ú ¿¬±¸ ¼¾ÅÍ¿¡¼ AI¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °£Áú, Á¾¾ç À¯Çü, ½Å°æ±³Á¾, ±Þ¼º ÇãÇ÷¼º Áúȯ, ³úµ¿¸Æ·ù Áø´ÜÀ» À§ÇÑ AIÀÇ Ã¤ÅÃÀÌ Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ±âÁ¸ ¼ö¼úº¸´Ù AI¸¦ Ȱ¿ëÇÑ ¼ö¼úÀÌ ´õ ³´´Ù´Â ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ÃÖ¼Òħ½À(MI), ºü¸¥ ȸº¹°ú ÀûÀº ÃâÇ÷À» °¡Á®¿À´Â AI ±â¹Ý ·Îº¿ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ¼ö¼ú ´É·ÂÀ» °ÈÇϱâ À§ÇÑ AIÀÇ Àû¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
The global artificial intelligence (AI) in neurology operating room market size reached USD 63.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,297 Million by 2033, exhibiting a growth rate (CAGR) of 39.8% during 2025-2033. The burgeoning healthcare industry, increasing utilization of AI in neurology operating rooms to predict cardiac and wound complications, and the growing demand for AI-based robotic surgeries represent some of the key factors driving the market.
Artificial intelligence (AI) is the simulation of human intelligence processes through computer programs and machines. It comprises expert systems, natural language processing, speech recognition, and machine vision. It relies on a foundation of enhanced hardware and software for writing and training machine learning (ML) algorithms. It is employed to reduce errors, perform risky tasks and automate various tasks without any breaks. It assists in collecting large amounts of labeled training data, analyzing the data for correlations and patterns, and using these patterns to make predictions about future states. It also aids in creating a specific task by acquiring data and converting the data into actionable information. At present, there is a rise in the demand for AI in the neurology operating room to enhance the performance of surgeons and reduce errors associated with neurosurgery.
The increasing demand for AI in neurology operating rooms to predict prognosis, identify potential post-operative complications, and track data for better aftercare and recovery represents one of the key factors supporting the market growth. Besides this, there is an increase in the utilization of AI in neurology operating rooms to identify risk factors and predict cardiac and wound complications and mortality among patients going through anterior cervical discectomy and fusion (ACDF) across the globe. This, along with the thriving healthcare industry, is propelling the growth of the market. In addition, the growing demand for AI in research centers of neurosurgery to collect, analyze, process, and disseminate data is offering a positive market outlook. Moreover, there is a rise in the employment of AI to diagnose epilepsy and tumor type, glioma, acute ischaemic events, and cerebral aneurysms around the world. This, coupled with the growing awareness among the masses about the benefits of AI-enabled surgeries over conventional surgeries, is positively influencing the market. Apart from this, the escalating demand for AI-based robotic surgeries that are minimally invasive (MI) and result in quick recovery and less blood loss is offering lucrative growth opportunities to industry investors. Additionally, the increasing application of AI to enhance remote surgical capabilities is bolstering the growth of the market.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report